Effects of α-lipoic acid on impaired gastric fundus innervation in diabetic rats

Free Radical Biology and Medicine

Volumn 35, Issue 2, 2003, Pages 160-168

  Gibson, T Michael ^a   Cotter, Mary A ^a   Cameron, Norman E ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Autonomic neuropathy; Diabetes mellitus; Free radicals; Gastric fundus; NANC; Nitric oxide; Oxidative stress

Indexed keywords

ANTIOXIDANT; ATROPINE; GUANETHIDINE; NEUROTRANSMITTER; NITRIC OXIDE; SEROTONIN; STREPTOZOCIN; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ELECTRIC FIELD; IN VITRO STUDY; MALE; MUSCLE RELAXATION; NEUROPATHY; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH FUNDUS; STOMACH INNERVATION;

EID: 0037823118     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00242-9     Document Type: Article

References (48)

1. Feldman M., Schiller L.R. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann. Intern. Med. 98:1983;378-384.
2. Abrahamsson H. Gastrointestinal motility disorders in patients with diabetes mellitus. J. Intern. Med. 237:1995;403-409.
3. Ballmann M., Conlon J.M. Changes in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the rat. Diabetologia. 28:1985;355-358.
4. Belai A., Lincoln J., Milner P., Crowe R., Loesch A., Burnstock G. Enteric nerves in diabetic rats increase in vasoactive intestinal polypeptide but not substance P . Gastroenterology. 95:1985;1234-1241.
5. Lucas P.M., Sardar A.M. Effects of diabetes on cholinergic transmission in two rat gut preparations. Gastroenterology. 100:1991;123-128.
6. Li C.G., Rand M.J. Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur. J. Pharmacol. 191:1990;303-309.
7. Boeckxstaens G.E., Pelckmans P.A., Bogers J.J., Bult H., De Man J.G., Oosterboch L., Herman A.G., Van Maercke Y.M. Release of nitric oxide upon stimulation of nonadrenergic noncholinergic nerves in the rat gastric fundus. J. Pharmacol. Exp. Ther. 256:1991;441-447.
8. Jenkinson K.M., Reid J.J. Effects of diabetes on relaxations to non-adrenergic, non-cholinergic nerve stimulation in longitudinal muscle of the rat gastric fundus. Br. J. Pharmacol. 116:1995;1551-1556.
9. Low P.A., Nickander K.K., Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 46:1997;S38-S42.
10. Cameron N.E., Cotter M.A. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Clin. Pract. 45:1999;137-146.
11. Packer L., Witt E.H., Tritschler H.J. Alpha-lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 19:1995;227-250.
12. Nagamatsu M., Nickander K.K., Schmelzer J.D., Raya A., Wittrock A., Tritschler H., Low P.A. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 18:1995;1160-1167.
13. Cameron N.E., Cotter M.A., Horrobin D.H., Tritschler H.J. Effects of α-lipoic acid on neurovascular function in diabetic rats interaction with essential fatty acids . Diabetologia. 38:1998;1425-1433.
14. Cameron N.E., Jack A.M., Cotter M.A. Effect of α-lipoic acid on vascular responses and nociception in diabetic rats. Free Radic. Biol. Med. 31:2001;125-135.
15. Obrosova I.G., Minchenko A.G., Marinescu V., Fathallah L., Kennedy A., Stockert C.M., Frank R.N., Stevens M.J. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia. 44:2001;1102-1110.
16. Obrosova I., Cao X., Greene D.A., Stevens M.J. Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism effect of DL-alpha-lipoic acid . Diabetologia. 41:1998;1442-1450.
17. Obrosova I.G., Fathallah L., Lie E., Nourooz-Zadeh J. Early oxidative stress in the diabetic kidney effect of DL-alpha-lipoic acid . Free Radic. Biol. Med. 34:2003;186-195.
18. Ziegler D., Hanefeld M., Ruhnau K.J., Meißner H.P., Lobisch M., Schütte K., Gries F.A. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 38:1995;1425-1433.
19. Ziegler D., Schatz H., Conrad F., Gries F.A., Ulrich H., Reichel G. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN study). Diabetes Care. 20:1997;369-373.
20. Keegan A., Cotter M.A., Cameron N.E. Effect of diabetes and treatment with the antioxidant, α-lipoic acid, on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia. 42:1999;343-350.
21. Jenkinson K.M., Reid J.J. Altered non-adrenergic non-cholinergic neuro-transmission in gastric fundus from streptozotocin-diabetic rats. Eur. J. Pharmacol. 401:2000;251-258.
22. Natraj C.V., Gandhi V.M., Menon K.K.G. Lipoic acid and diabetes effect of dihydrophilic acid administration in diabetic rats and rabbits . J. Biosci. 6:1984;37-46.
23. Wagh S.S., Natraj C.V., Menon K.K.G. Mode of action of lipoic acid in diabetes. J. Biosci. 11:1987;59-74.
24. Lyall F., Gibson J.L., Greer I.A., Brockman D.E., Eis A.L.W., Myatt L. Increased nitrotyrosine in the diabetic placenta evidence for oxidative stress . Diabetes Care. 21:1998;1753-1758.
25. Du X.L., Stockklauser-Faber K., Rösen P. Generation of reactive oxygen intermediates, activation of NF-kappa B, and induction of apoptosis in human endothelial cells by glucose role of nitric oxide synthase? Free Radic. Biol. Med. 27:1999;752-763.
26. Coppey L.J., Gellett J.S., Davidson E.P., Dunlap J.A., Lund D.D., Salvemini D., Yorek M.A. Effects of M40403 treatment of diabetic rats on epineurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Br. J. Pharmacol. 134:2001;21-29.
27. Ellis E.A., Guberski D.L., Hutson B., Grant M.B. Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide. 6:2002;295-304.
28. Szabo C., Zanchi A., Komjati K., Pacher P., Krowleski A.S., Quist W.C., LoGerfo F.W., Horton E.S., Veves A. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation. 106:2002;2680-2686.
29. Cameron N.E., Cotter M.A. Neurovascular deficits in diabetic rats potential contribution of autoxidation and free radicals examined using transition metal chelating agents . J. Clin. Invest. 96:1995;1159-1163.
30. Keegan A., Cotter M.A., Cameron N.E. Effects of chelator treatment on aorta and corpus cavernosum from diabetic rats. Free Radic. Biol. Med. 27:1999;536-543.
31. Inkster M.E., Cotter M.A., Cameron N.E. Effects of trientine, a metal chelator, on defective endothelium-dependent relaxation in the mesenteric vasculature of diabetic rats. Free Radic. Res. 36:2002;1091-1099.
32. Pieper G.M., Siebeneich W. Diabetes-induced endothelial dysfunction is prevented by long term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. J. Cardiovasc. Pharmacol. 30:1997;734-738.
33. Cotter M.A., Love A., Watt M.J., Cameron N.E., Dines K.C. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia. 38:1995;1285-1294.
34. Cameron N.E., Cotter M.A., Archibald V., Dines K.C., Maxfield E.K. Anti-oxidant and pro-oxidant effects on nerve conduction velocity and endoneurial blood flow and oxygen tensions in non-diabetic and streptozotocin-diabetic rats. Diabetologia. 37:1994;449-459.
35. Cameron N.E., Livingstone I., Schyma B., Cotter M.A. Iron, diabetes and neurovascular dysfunction (abstract). Free Radic. Biol. Med. 33:(Suppl. 2):2002;S328.
36. 1 receptor antagonist . Am. J. Physiol. 269:1995;E530-E537.
37. Cameron N.E., Cotter M.A., Dines K.C., Maxfield E.K. Pharmacological manipulation of vascular endothelium in non-diabetic and streptozotocin-diabetic rats effects on nerve conduction, hypoxic resistance and endoneurial capillarization . Diabetologia. 36:1993;516-522.
38. Cameron N.E., Cotter M.A. Diabetes causes an early reduction in autonomic ganglion blood flow in rats. J. Diabetes Complications. 15:2001;198-202.
39. Sasaki H., Schmelzer J.D., Zollman P.J., Low P.A. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats. Acta Neuropathol. (Berl.). 93:1997;118-128.
40. D'Amato M., Currò D. Evidence for dual components in the non-adrenergic non-cholinergic relaxation the rat gastric fundus role of endogenous nitric oxide and vasoactive intestinal polypeptide . J. Auton. Nerv. Syst. 37:1992;175-186.
41. Elabbady A.A., Gagnon C., Hassouna M.M., Begin L.R., Elhilali M.M. Diabetes mellitus increases nitric oxide synthase in penises but not in major pelvic ganglia of rats. Br. J. Urol. 76:1995;196-202.
42. Sullivan M.E., Bell C.R.W., Dashwood M.R., Miller M.A.W., Thompson C.S., Mikhailidis D.P., Morgan R.J. Autoradiographic localization of nitric oxide synthase binding-sites in normal and diabetic rat corpus cavernosum. Eur. Urol. 30:1996;506-511.
43. Stockklauser-Farber K., Ballhausen T., Laufer A., Rösen P. Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim. Biophys. Acta. 1535:2000;10-20.
44. Jenkinson K.M., Reid J.J. Evidence that adenosine 5′-triphosphate is the third inhibitory non-adrenergic non-cholinergic neurotransmitter in the rat gastric fundus. Br. J. Pharmacol. 130:2000;1627-1631.
45. Higham A., Vaillant C., Yegen B., Thompson D.G., Dockray G.J. Relation between cholecystokinin and antral innervation in the control of gastric emptying in the rat. Gut. 41:1997;24-32.
46. Ordog T., Takayama I., Cheung W.K., Ward S.M., Sanders K.M. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes. 49:2000;1731-1739.
47. Ishiguchi T., Nakajima M., Sone H., Tada H., Kumagai A.K., Takahashi T. Gastric distension-induced pyloric relaxation central nervous system regulation and effects of acute hyperglycaemia in the rat . J. Physiol. 533:2001;801-813.
48. El-Salhy M., Spangeus A. Gastric emptying in animal models of human diabetes correlation to blood glucose level and gut neuropeptide content . Ups. J. Med. Sci. 107:2002;89-99.